Skip to content

Based on a multi-disease sharing genetic research platform to explore the brain imaging and multi-omics mechanism of three common mental disorders before and after modified electroconvulsive therapy

Based on a multi-disease sharing genetic research platform to explore the brain imaging and multi-omics mechanism of three common mental disorders before and after modified electroconvulsive therapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031858
Enrollment
Unknown
Registered
2020-04-12
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, depression, bipolar disorder

Interventions

case group:modified electroconvulsive therapy
healthy control group:N/A

Sponsors

Institute of Mental Health, the Sixth Hospital of Peking University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Patients with clear clinical diagnosis, clinical condition requiring MECT + drug treatment and suitable for MECT: inpatients and outpatients who meet the diagnostic criteria of DSM-IV schizophrenia, depressive disorder and bipolar disorder through SCID structured interview from March 2020 to December 2021 in the Sixth Hospital of Peking University; 2. Patients who meet the indications of MECT, have no MECT and anesthesia contraindications, and need to receive MECT; 3. Patients between 18-45 years old, male and female unlimited; 4. The patients who are in the acute attack stage can have the first episode or relapse; 5. Patients with IQ > 70; 6. Patients willing to sign informed consent and cooperate with the study. Recruitment criteria of healthy volunteers: 1. Subjects who are healthy and have not suffered from known genetic diseases; 2. Subjects without DSM-IV Axis I mental illness; 3. Objects with IQ > 70; 4. Willing to sign informed consent and cooperate with the research object.

Exclusion criteria

Exclusion criteria: Mental disorders: 1. Patients with serious physical diseases, such as serious cardiovascular and cerebrovascular diseases, serious respiratory diseases, serious liver, kidney, endocrine, blood diseases, malignant tumors, etc; 2. Patients with organic mental disorder, alcohol or drug dependence, clearly diagnosed cognitive impairment and personality disorder; 3. Patients not suitable for MECT; 4. Patients with metal substances in the body and not suitable for head MRI (plain scan + hippocampus) examination; Lactation, pregnancy, pregnant women; 5. Patients who cannot sign informed consent. Healthy volunteers: 1. Objects with a history of loss of consciousness for more than 5 minutes; 2. Objects with a history of alcohol or substance abuse / dependence in the past year; 3. Objects with contraindications of MRI (some special people can't do MRI, such as pregnancy, patients with pacemaker, patients with aneurysm clip after craniocerebral operation, patients with ferromagnetic implants, patients with artificial metal valve after cardiac operation, patients with alloy prosthesis or metal joint, patients with insulin pump or nerve stimulator in vivo, etc.).

Design outcomes

Primary

MeasureTime frame
ECS-ISF;Genotypes, methylation and metabolomics of candidate genes;

Countries

China

Contacts

Public ContactYue Weihua

Institute of Mental Health, the Sixth Hospital of Peking University

dryue@bjmu.edu.cn+86 10 82805307

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026